FGF7 and COVID-19: A plot of the serum FGF7 concentration against age showed that 72% of nondiabetic patients with mild COVID-19 and 79% of nondiabetic patients with severe symptoms were above the 13.7 ng/ml with more elderly patients in the severe group.